2012
DOI: 10.1016/j.neuropharm.2012.06.041
|View full text |Cite
|
Sign up to set email alerts
|

Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 35 publications
0
5
0
Order By: Relevance
“…Although we do not have a precise explanation for why the hyperalgesic action of HK-1 presumably at the NK1 receptors is not observed when SP and NKA are also missing from the system, some hypothesis can be made: a) HK-1 exerts its hyperalgesic effect in the nociceptive pathway through the NK1 tachykinin receptor, but it is counteracted by NKA acting at NK2 receptors in the central nervous system [53], b) HK-1 and SP act at the same receptors (NK1), but they might have different binding sites, affinities and intinsinc efficacies, as well as distinct activation mechanisms and signalling pathways. When both are removed from the system, the inhibition observed in case of the HK-1 absence, might be counteracted via intracellular molecular mechanisms.…”
Section: Discussionmentioning
confidence: 93%
“…Although we do not have a precise explanation for why the hyperalgesic action of HK-1 presumably at the NK1 receptors is not observed when SP and NKA are also missing from the system, some hypothesis can be made: a) HK-1 exerts its hyperalgesic effect in the nociceptive pathway through the NK1 tachykinin receptor, but it is counteracted by NKA acting at NK2 receptors in the central nervous system [53], b) HK-1 and SP act at the same receptors (NK1), but they might have different binding sites, affinities and intinsinc efficacies, as well as distinct activation mechanisms and signalling pathways. When both are removed from the system, the inhibition observed in case of the HK-1 absence, might be counteracted via intracellular molecular mechanisms.…”
Section: Discussionmentioning
confidence: 93%
“…10,15,[24][25][26][27][28] The doses of the NK1R antagonists (10 nmols per MNA) were based on previous publications. 6,24,25,27,[29][30][31] Coadministration of NK1R antagonist at the sensitization site, incorporated with hapten in MNA or injected i.…”
Section: Skin Codelivery Of Hapten and Nk1r Antagonists Integrated In...mentioning
confidence: 99%
“…However, to date, this claim remains controversial as studies have shown contradictory results. An extensive study conducted by Tauer et al, [218] using NK-1R −/− mice and selective high affinity non peptide NK-1R, NK-2R and NK-3R receptor antagonists revealed that there is a significant probability that the central actions of NKA could be mediated by a cross talk between NK-1R and NK-2R receptors. This study could be used as a reference point in studying the role of NKA in cardiac remodeling since isolated neonatal cardiomyocytes have been shown to express the gene for NK-1R and NK-3R receptors, though not NK-2R receptor.…”
Section: 0 Additional Neuropeptidesmentioning
confidence: 99%